This application relates generally to the field of medical devices and treatments. In particular, the application relates to systems, devices and methods for treating the soft palate and possibly other parts of the mouth, to improve breathing and specifically to treat snoring and/or sleep apnea.
Snoring and sleep apnea are extremely prevalent and significant health issues in the United States and other parts of the world. Sleep apnea is defined as the cessation of breathing during sleep. Obstructive sleep apnea (OSA) is the most common form of sleep apnea, and it is often linked to obesity, which is becoming an ever more prevalent health condition. OSA occurs when the tissues in the back of the throat repetitively collapse during sleep, producing snoring and complete airway blockage. This blockage creates pauses in breathing that occur repeatedly every night. In severe cases, they can occur as frequently as every 30 seconds. Alarmingly, they can last up to a full minute.
The repetitive pauses in breathing during sleep in an OSA sufferer are accompanied by a reduction in blood oxygen levels and are followed by an arousal response. This response includes a release of substances into the bloodstream, which promote elevation of blood pressure, inflammation, insulin resistance, and a disruption of the brain wave sleep pattern. The consequences of untreated sleep apnea include poor quality sleep, excessive daytime fatigue and sleepiness, irritability, hard-to-control high blood pressure and diabetes, heart disease and stroke. Moreover, untreated sleep apnea may be responsible for job impairment and motor vehicle crashes.
Snoring, which is typically a less serious and severe condition than sleep apnea, still has significant effects on people who suffer from it and their loved ones. Snoring can affect a person's sleep and of course can also disrupt the sleep of a spouse, sibling or others who are sleeping nearby.
Many different methods and devices have been developed and tested for treating sleep apnea and snoring, but no perfect solution has yet been discovered. Some treatments for sleep apnea involve major, invasive surgery, for example to remove portions of the tongue and/or throat or to place mechanical slings or other implants in the tongue, in an effort to prevent the tongue from falling back in the mouth during sleep. Less invasive techniques, such as wearing an adhesive nasal strip to bed each night, are usually less effective or do not work at all, since many OSA patients are either already mouth breathers or convert to mouth breathing when a nasal blockage is addressed.
Therefore, it would be highly advantageous to have improved systems, devices and methods for treating sleep apnea and snoring. Ideally, these improved systems and techniques would be relatively less invasive than most of the surgical techniques used currently or tried in the past, while still working effectively for many patients. It would also be ideal if these techniques did not involve implants. The present disclosure will address at least some of these objectives.
Embodiments of the present application are directed to devices, systems and methods for treating the soft palate and possibly other areas of the mouth and/or throat, to treat sleep apnea and/or snoring. Various embodiments may be used to reshape, remodel, strengthen, stiffen or change properties of tissues of the soft palate, including but not limited to skin, muscle, mucosa, submucosa and/or cartilage of the soft palate. This change in the soft palate may prevent collapse of the soft palate or vibration of the soft palate during nighttime breathing and thus prevent or at least reduce OSA and/or snoring.
According to one aspect of the present disclosure, a method of treating a soft palate in a patient to treat sleep apnea, snoring or both may involve advancing a treatment element of a treatment device through the patient's mouth, contacting a tissue-contact surface of the treatment element with the soft palate, delivering energy to the soft palate via one or more energy delivery members on the tissue-contact surface, and removing the treatment element from the mouth. In some embodiments, the energy delivery members are two rows of bipolar, radiofrequency electrode pairs protruding from the tissue-contact surface, and delivering the energy involves delivering radiofrequency energy between the two rows of electrode pairs, to reshape, remodel, strengthen and/or change a property of the soft palate.
In some embodiments, the method may also involve applying force against the soft palate with the tissue-contact surface to at least temporarily deform tissue of the soft palate. Some embodiments may also involve forming an incision in mucosal tissue of the soft palate, in which case the energy may be delivered to submucosal tissue. The type of delivered energy may be radiofrequency (monopolar or bipolar), microwave, ultrasound, heat, cryogenic energy (energy removal) or the like. The method may also involve repositioning the treatment element to a new location on the soft palate and repeating the delivering step, before removing the treatment element from the mouth. This may be repeated as many times as desired, to cover a given area of the soft palate.
Optionally, some embodiments may also include injecting a substance into the soft palate before applying energy to the tissue. For example the substance may be an agent that increases conductivity of the tissue or enhances softening, stiffening or other tissue changes. Such an injection may be performed using conventional techniques and device, such as a syringe, or alternatively a treatment device may include a built-in injection device.
In another aspect of the disclosure, a device for treating a soft palate in a patient to treat sleep apnea, snoring or both may include a handle, a shaft, a treatment element, and a connector for connecting the handle with a power source. The shaft may include a distal end with a neck, and the treatment element may extend from the neck and may be angled relative to a longitudinal axis of the shaft. The treatment element may include a treatment surface and at least one energy delivery member on the treatment surface. In some embodiments, the energy delivery member comprises two rows of bipolar, radiofrequency electrode pairs protruding from the tissue-contact surface. The electrodes may be triangular in shape, for example. In some embodiments, the treatment surface has a convex shape for creating a concave deformity in the soft palate. In some embodiments, the device may have multiple shafts and multiple treatment elements, where each of the treatment elements is located on one of the multiple shafts.
These and other aspects and embodiments are described further below, in relation to the attached drawing figures.
Certain embodiments and modifications thereof will become apparent from the detailed description below, having reference to the figures that follow.
The assignee of the present application has developed a number of devices, systems and methods for delivering energy to tissues in the nasal passages to treat nasal valve insufficiency, post nasal drip and other breathing abnormalities and disorders of the nasal passages. The systems generally include an energy delivery console (or “box”) and a hand piece for delivering the therapy to the nasal tissue. The hand piece typically includes a handle, a shaft, and a treatment delivery element at or near the end of the shaft for delivering the energy to the tissues. One general type of embodiment includes one handle, one shaft and one treatment element for advancing through a nostril. Another general type of embodiment includes a clamp-like configuration, with two handles, two shafts and two treatment elements, where tissue is clamped between the two tissue elements, which are either advanced through both nostrils or through one nostril and an outside of the nose. In general, the method of treatment involves applying force to a tissue to be treated with the treatment element, to deform the tissue, and applying energy to the tissue with the treatment element. When the treatment is stopped and the treatment element is removed, the target tissue is reformed or changed in some other way and retains at least some of that change after the treatment is complete. In one embodiment, the treatment element delivers bipolar radiofrequency (RF) energy from multiple electrodes on the treatment element, although many other energy modalities and treatment element configurations are possible.
Patents describing various embodiments of these tissue treatment devices, systems and methods include U.S. Pat. Nos. 8,936,594; 9,237,924; 9,433,463; 9,415,194; 9,452,087 and 9,433,463. All of these patents, referred to herein as “the Incorporated Patents,” are hereby incorporated by reference herein in their entireties. Any of the embodiments described in the Incorporated Patents may be used or adapted for use in treating the soft palate and/or other mouth or throat structures to treat OSA and/or snoring. The many embodiments of methods, devices and systems described in the Incorporated Patents will not be repeated in this application, but again, any embodiments described there may be used or adapted for use in performing the methods described herein for treating OSA and/or snoring.
Device 550 may either include a generator or be connected to a remote generator. Device 550 may include a flexible wire or cable 564 that connects to an adaptor 566 that is configured to be plugged into a remote generator (not shown). Adaptor 566 may allow transmission of treatment energy between a remote generator and the device 550. Adaptor 566 may also allow transmission of any sensor signals between device 550 and a generator or control unit. Treatment device 550 may be provided in a system or kit also including the remote generator. The system or kit (with or without the remote generator) may also include a grounding device and/or a cooling device as described above and further below. In some embodiments, the kit includes a positioning element (e.g., a “cottle” device) configured to help a user locate the optimal treatment area.
In some embodiments, shaft 558 has a width or diameter or about 0.235 inches to about 0.25 inches. In some embodiments, the shaft is about 1.5 inches to about 4 inches long. In some embodiments, the shaft and/or handle is made of a polymer such as polycarbonate or PEEK. In other embodiments, the shaft is made of stainless steel or other metals. The metals may be coated with an external and/or internal insulating coating (e.g., polyester, polyolefin, etc.). Handle 560 may be made of the same material as shaft 558, in some embodiments. In some embodiments, the shaft 558 is rigid. This may allow a user of device 550 increased control over the deformation of soft palate tissue. In other embodiments, shaft 558 may be flexible. This flexibility may allow a user adjust an angle of distal tip 556 by bending shaft 558. In some embodiments, this tip-to-shaft angle may be adjustable, for example via a locking hinge or other similar mechanism. In some embodiments, distal tip 556 may be flexible or pre-curved along its length, so that it better conforms to the tissue of the soft palate.
Treatment element 552 may include a monopolar or bipolar array of RF needles 554. In some embodiments, needles 554 are energized in between select needles to deliver bipolar energy. In other embodiments, the energy is delivered between needles 554 and a remote grounding pad (not shown). In some embodiments, electrode needle pairs 554 are arranged horizontally across treatment element 552. In some embodiments, electrode needle pairs 554 are arranged vertically across treatment element 552, or along the direction of shaft 558 and handle 560. Other configurations are also possible. For example, needle pairs 554 may be arranged diagonally across treatment element 552. Treatment element 552 may be placed either internally, with needle pairs 554 positioned transmucosally, or treatment element 552 may be placed externally with needle pairs 554 positioned transdermally. Distal tip 556 of device 550 may also function as a mold or molding element. In a monopolar embodiment, the energy may be selectively delivered between certain sets of needles, all needles, or even individual needles to optimize the treatment effect.
Treatment element 552 of the device 550 further comprises a pin-shaped structure comprising a thermocouple 555 within an insulating bushing extending through a middle portion of the front surface of the treatment element 552. In some embodiments, different heat sensors (e.g., thermistors) may be used. In some embodiments, thermocouple 555 may be configured to measure a temperature of the surface or subsurface of tissue to be treated or tissue near the tissue to be treated. A pin shape having a sharp point may allow the structure to penetrate the tissue to obtain temperature readings from below the surface. Thermocouple 555 can also be configured to measure a temperature of the treatment element 552. The temperature measurements taken by thermocouple 555 can be routed as feedback signals to a control unit, and the control unit can use the temperature measurements to adjust the intensity of energy being delivered through electrodes 554. In some embodiments, thermocouple 555 or other sensing devices may be used to measure multiple tissue and device parameters. For example, multiple thermocouples 555 or thermistors may be used to measure a temperature at different locations along the treatment element. In some embodiments, one of the sensors may be configured to penetrate deeper into the tissue to take a measurement of a more interior section of tissue. For example, device 550 may have multiple sensors configured to measure a temperature at the mucosa, the cartilage, and/or treatment element 552. As described above, in some embodiments, the sensors described herein are configured to take a measurement of a different parameter. For example, tissue impedance can be measured. These measurements can be used to adjust the intensity and/or duration of energy being delivered through the treatment element. This type of feedback may be useful from both an efficacy and a safety perspective.
In some embodiments, treatment element 552 has a width or diameter of about 0.25 inches to about 0.45 inches. In some embodiments, treatment element 552 is about 0.4 inches to about 0.5 inches long. Treatment element 552 can, in some embodiments, comprise a ceramic material (e.g., zirconium, alumina, silicon glass). Such ceramics may advantageously possess high dielectric strength and high temperature resistance. In some embodiments, treatment element 522 may include polyimides or polyamides, which may advantageously possess good dielectric strength and elasticity and be easy to manufacture. In some embodiments, treatment element 552 may include thermoplastic polymers. Thermoplastic polymers may advantageously provide good dielectric strength and high elasticity. In some embodiments, treatment element 552 may include thermoset polymers, which may advantageously provide good dielectric strength and good elasticity. In some embodiments, treatment element 552 may include glass or ceramic infused polymers. Such polymers may advantageously provide good strength, good elasticity, and good dielectric strength.
In some embodiments, electrodes 554 have a width or diameter of about 0.15 inches to about 0.25 inches. In some embodiments, electrodes 554 are about 0.2 inches to about 0.5 inches long. In some embodiments, electrodes 554 may be made of steel (e.g., stainless, carbon, alloy). Steel may advantageously provide high strength while being low in cost and minimally reactive. In some embodiments, electrodes 554 or other energy delivery elements described herein comprise materials such as platinum, gold, or silver. Such materials may advantageously provide high conductivity while being minimally reactive. In some embodiments, electrodes 554 or other energy delivery elements described herein may include titanium, which may advantageously possess a high strength to weight ratio and be highly biocompatible. In some embodiments, electrodes 554 or other energy delivery elements described herein may include nickel titanium alloys. These alloys may advantageously provide high elasticity and be biocompatible. Other similar materials are also possible.
Energy applied to the tissue to be treated using any combination of the embodiments described in this application may be controlled by a variety of methods. In some embodiments, temperature or a combination of temperature and time may be used to control the amount of energy applied to the tissue. Tissue is particularly sensitive to temperature, so providing just enough energy to reach the target tissue may provide a specific tissue effect, while minimizing damage resulting from energy causing excessive temperature readings. For example, a maximum temperature may be used to control the energy. In some embodiments, time at a specified maximum temperature may be used to control the energy. In some embodiments, thermocouples, such as those described above, are provided to monitor the temperature at the electrode and provide feedback to a control unit. In some embodiments, tissue impedance may be used to control the energy. Impedance of tissue changes as it is affected by energy delivery. By determining the impedance reached when a tissue effect has been achieved, a maximum tissue impedance can be used to control energy applied.
In the embodiments described herein, energy may be produced and controlled via a generator that is either integrated into the electrode hand piece or as part of a separate assembly that delivers energy or control signals to the hand piece via a cable or other connection. In some embodiments, the generator is an RF energy source configured to communicate RF energy to the treatment element. For example, the generator may comprise a 460 KHz sinusoid wave generator. In some embodiments, the generator is configured to run between about 1 and 100 watts. In some embodiments, the generator is configured to run between about 5 and about 75 watts. In some embodiments, the generator is configured to run between about 10 and 50 watts.
In some embodiments, the energy delivery element comprises a monopolar electrode. Monopolar electrodes are used in conjunction with a grounding pad. The grounding pad may be a rectangular, flat, metal pad. Other shapes are also possible. The grounding pad may comprise wires configured to electrically connect the grounding pad to an energy source (e.g., an RF energy source).
In some embodiments, the energy delivery element such as the electrodes described above can be flat. Other shapes are also possible. For example, the energy delivery element can be curved or comprise a complex shape. For example, a curved shape may be used to place pressure or deform the tissue to be treated. The energy delivery element may comprise needles or microneedles. The needles or microneedles may be partially or fully insulated. Such needles or microneedles may be configured to deliver energy or heat to specific tissues while avoiding tissues that should not receive energy delivery.
In some embodiments, the non-electrode portion of treatment element 552 may include an insulating material, such as a ceramic material (e.g., zirconium, alumina, silicon glass). In some embodiments, treatment elements 552 may include an insulating material interposed between multiple electrodes 554 or electrode sections. These insulating sections may provide an inert portion of the treatment element that does not delivery energy to the tissue. Such ceramics may advantageously possess high dielectric strength and high temperature resistance. In some embodiments, the insulators described herein comprise polyimides or polyamides which may advantageously possess good dielectric strength and elasticity and be easy to manufacture. In some embodiments, the insulators described herein comprise thermoplastic polymers. Thermoplastic polymers may advantageously provide good dielectric strength and high elasticity. In some embodiments, the insulators described herein comprise thermoset polymers, which may advantageously provide good dielectric strength and good elasticity. In some embodiments, the insulators described herein comprise glass or ceramic infused polymers. Such polymers may advantageously provide good strength, good elasticity, and good dielectric strength.
In some embodiments, handle 560 and/or shaft 558 may include the same materials as those described with respect to the insulators. In some embodiments, handle 560 and/or shaft 558 may include a metal, such as stainless steel. In other embodiments, handle 560 and/or shaft 558 may include a polymer, such as polycarbonate. Other metals and polymers are also contemplated.
In some embodiments, device 550 may be used in conjunction with a positioning element that can be used to aid in positioning of the device. The positioning element may be integrated into the device itself or can be separate. The positioning element may be used to determine the optimal placement of the device to achieve maximal increase in efficacy. In some embodiments, a positioning element is configured to be inserted and manipulated within the mouth until the patient reports a desired improvement in breathing. Device 550 may then be used to treat, while the positioning element is holding the mouth in the desired configuration. In some embodiments, molds described herein may be used for the same purpose.
In some embodiments, a positioning element may include a shaft, including measurement marks indicating depth. For example, a physician may insert this element into the mouth to manipulate the tissue to find the depth of treatment at which the soft palate is contacted. The positioning element may also comprise marks indicating angle of insertion. The physician may then use the measurement marks to guide insertion of the treatment element to the same spot.
Embodiments of devices configured to heat specific tissue while maintaining lower temperatures in other adjacent tissue are provided. These devices may be incorporated into any of the treatment apparatuses and methods described herein. The soft palate is an example of a tissue complex that includes adjacent tissues that may benefit from being maintained at different temperatures. Other examples include the skin, which comprises the epidermis, dermis, and subcutaneous fat, the tonsils, which comprise mucosa, glandular tissue, and vessels. Treatment of other tissue complexes is also possible. For example, in some embodiments, the internal structures of the soft palate may be heated, while maintaining a lower temperature in the mucosal lining of the mouth and/or skin. In other embodiments, the mucosa may be heated, while maintaining lower temperatures in the skin. Limiting unwanted heating of non-target tissues may allow trauma and pain to be reduced, may reduce scarring, may preserve tissue function, and may also decrease healing time. Combinations of heat transfer and/or heat isolation may allow directed treatment of specific tissue such as cartilage, while excluding another tissue, such as mucosa, without surgical dissection.
Referring now to
As mentioned above, the treatment may be used to change the shape, strength, stiffness or any other property of any soft palate tissue, such as but not limited to mucosa, cartilage and collagen. In embodiments where the shape of the soft palate is changed during the treatment, at least some of this change in shape will be retained after the treatment. In addition to treating the soft palate, some treatment method embodiments may also include treating other nearby tissues of the mouth, throat, tongue, etc. Also, the upper, treatment surface portion of treatment element 106 may include any suitable energy delivery device and may have any suitable shape for addressing the soft palate. For example, treatment element 106 may deliver energy in the form of bipolar RF, monopolar RF, ultrasound, cryotherapy (energy removal), heat, chemical, microwave or any other suitable type of energy, and it may include any number of energy delivery members. The shape of the treatment surface may be convex, concave or flat and may have any shape, such as ovoid, rectangular, triangular, asymmetric, etc.
Referring to
As illustrated, in this embodiment, treatment surface 210 is relative long and flat. This shape may be ideal for treating soft palate (and possibly other tissue in the mouth or throat) to treat OSA and/or snoring. On the other hand, treatment surface 210 may have a convex or other shape in alternative embodiments, to help deform soft palate tissue into a desired configuration. Whatever the shape of surface 210, electrodes 212 are used to apply RF energy to the target tissue, to cause heating and eventual shrinking, stiffening and/or reshaping of the soft palate. The resulting treatment effect may include volume reduction, tissue stiffening (higher modulus) and/or stiffening by way of more optimal structure (e.g., arched tissue with a higher second moment of inertia, better bending stiffness, etc.). Radiofrequency energy may be controlled via temperature feedback, such as a thermocouple and RF power controller, and/or may be controlled to impart a specific total energy. Device 200 may also be used with minimal built-in control and applied by the physician under visualization until the intended effect on the target tissue has been achieved. In alternative embodiments, alternate energy sources may include cryogenic surface cooling, combinations of cooling and heating technologies, cauterizing agents, ultrasound or the like.
With reference now to
Again, any of the embodiments described in the Incorporated Patents may be used to treat the soft palate for addressing OSA and/or snoring, and any features described in the Incorporated Patents may be incorporated into the designs described herein.
Referring now to
Again, any of the features described in the Incorporated Patents may be incorporated into device 400, according to various embodiments. Although no incisions have been described above, in some embodiments, the treatment method may involve forming a small incision in the mucosa of the soft palate and advancing the treatment element through the incision to contact and treat tissue underlying the mucosa. Such embodiments are described more fully in some of the Incorporated Patents.
Although various embodiments are described herein, the present invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and modifications and equivalents thereof. Thus, the scope of the present invention should not be limited by the disclosed embodiments, but should be determined only by a fair reading of the claims that follow.
This application claims priority to U.S. Provisional Patent Application Ser. No. 62/438,300, titled “Soft Palate Treatment,” filed Dec. 22, 2016. The aforementioned provisional patent application is hereby incorporated fully by reference.
Number | Name | Date | Kind |
---|---|---|---|
4887605 | Angelsen et al. | Dec 1989 | A |
5348008 | Bomn et al. | Sep 1994 | A |
5533499 | Johnson | Jul 1996 | A |
5542916 | Hirsch et al. | Aug 1996 | A |
5624439 | Edwards et al. | Apr 1997 | A |
5674191 | Edwards et al. | Oct 1997 | A |
5707349 | Edwards | Jan 1998 | A |
5718702 | Edwards | Feb 1998 | A |
5728094 | Edwards | Mar 1998 | A |
5730719 | Edwards | Mar 1998 | A |
5733280 | Avitall | Mar 1998 | A |
5738114 | Edwards | Apr 1998 | A |
5743870 | Edwards | Apr 1998 | A |
5743904 | Edwards | Apr 1998 | A |
5746224 | Edwards | May 1998 | A |
5800429 | Edwards | Sep 1998 | A |
5807306 | Shapland et al. | Sep 1998 | A |
5816095 | Nordell, II et al. | Oct 1998 | A |
5817049 | Edwards | Oct 1998 | A |
5820580 | Edwards et al. | Oct 1998 | A |
5823197 | Edwards | Oct 1998 | A |
5827277 | Edwards | Oct 1998 | A |
5843021 | Edwards | Dec 1998 | A |
5843077 | Edwards | Dec 1998 | A |
5846235 | Pasricha et al. | Dec 1998 | A |
5879349 | Edwards | Mar 1999 | A |
5938659 | Tu | Aug 1999 | A |
6026816 | McMillan et al. | Feb 2000 | A |
6045549 | Smethers et al. | Apr 2000 | A |
6096033 | Tu et al. | Aug 2000 | A |
6102907 | Smethers et al. | Aug 2000 | A |
6109268 | Thapliyal et al. | Aug 2000 | A |
6126657 | Edwards et al. | Oct 2000 | A |
6131579 | Thorson et al. | Oct 2000 | A |
6139546 | Koenig et al. | Oct 2000 | A |
6152143 | Edwards | Nov 2000 | A |
6165173 | Kamdar et al. | Dec 2000 | A |
6179803 | Edwards et al. | Jan 2001 | B1 |
6210355 | Edwards et al. | Apr 2001 | B1 |
6228079 | Koenig | May 2001 | B1 |
6231569 | Bek et al. | May 2001 | B1 |
6293941 | Strul et al. | Sep 2001 | B1 |
6309386 | Bek | Oct 2001 | B1 |
6371926 | Thorson et al. | Apr 2002 | B1 |
6383181 | Johnston et al. | May 2002 | B1 |
6391028 | Fanton et al. | May 2002 | B1 |
6416491 | Edwards et al. | Jul 2002 | B1 |
6425151 | Bamett | Jul 2002 | B2 |
6431174 | Knudson et al. | Aug 2002 | B1 |
6451013 | Bays et al. | Sep 2002 | B1 |
6502574 | Stevens | Jan 2003 | B2 |
6551310 | Ganz et al. | Apr 2003 | B1 |
6562036 | Ellman et al. | May 2003 | B1 |
6575969 | Rittman et al. | Jun 2003 | B1 |
6589235 | Wong et al. | Jul 2003 | B2 |
6659106 | Hovda et al. | Dec 2003 | B1 |
6911027 | Edwards et al. | Jun 2005 | B1 |
6978781 | Jordan | Dec 2005 | B1 |
7055523 | Brown | Jun 2006 | B1 |
7097641 | Arless et al. | Aug 2006 | B1 |
7114495 | Lockwood, Jr. | Oct 2006 | B2 |
7322993 | Metzger et al. | Jan 2008 | B2 |
7416550 | Protsenko et al. | Aug 2008 | B2 |
7442191 | Hovda et al. | Oct 2008 | B2 |
7678069 | Baker et al. | Mar 2010 | B1 |
7780730 | Saidi | Aug 2010 | B2 |
7824394 | Manstein | Nov 2010 | B2 |
7850683 | Elkins et al. | Dec 2010 | B2 |
8128617 | Bencini et al. | Mar 2012 | B2 |
8137345 | McNall, III et al. | Mar 2012 | B2 |
8317781 | Owens et al. | Nov 2012 | B2 |
8317782 | Ellman et al. | Nov 2012 | B1 |
D716325 | Brudnicki | Oct 2014 | S |
8925551 | Sanders | Jan 2015 | B2 |
8936594 | Wolf et al. | Jan 2015 | B2 |
8986301 | Wolf et al. | Mar 2015 | B2 |
9072597 | Wolf et al. | Jul 2015 | B2 |
9119954 | Burdette et al. | Sep 2015 | B2 |
9125677 | Sobol | Sep 2015 | B2 |
9179964 | Wolf et al. | Nov 2015 | B2 |
9179967 | Wolf et al. | Nov 2015 | B2 |
9237924 | Wolf et al. | Jan 2016 | B2 |
9452087 | Holm et al. | Jan 2016 | B2 |
D763910 | Drozd et al. | Aug 2016 | S |
D765091 | Del Lima et al. | Aug 2016 | S |
9415194 | Wolf et al. | Aug 2016 | B2 |
D765718 | Vinna et al. | Sep 2016 | S |
9433463 | Wolf et al. | Sep 2016 | B2 |
9452010 | Wolf et al. | Sep 2016 | B2 |
9486278 | Wolf et al. | Nov 2016 | B2 |
9526571 | Wolf et al. | Dec 2016 | B2 |
9526652 | Harrison et al. | Dec 2016 | B2 |
D776717 | Asai | Jan 2017 | S |
D789383 | Bawazeer et al. | Jun 2017 | S |
9687288 | Saadat | Jun 2017 | B2 |
9687296 | Wolf et al. | Jun 2017 | B2 |
D795898 | Li et al. | Aug 2017 | S |
D797756 | Meyer et al. | Sep 2017 | S |
9763723 | Saadat | Sep 2017 | B2 |
9763743 | Lin | Sep 2017 | B2 |
9788886 | Wolf et al. | Oct 2017 | B2 |
9801752 | Wolf et al. | Oct 2017 | B2 |
9888957 | Wolf et al. | Feb 2018 | B2 |
9913682 | Wolf et al. | Mar 2018 | B2 |
9943361 | Wolf et al. | Apr 2018 | B2 |
10028780 | Wolf et al. | Jul 2018 | B2 |
10028781 | Saadat | Jul 2018 | B2 |
D840428 | Narinedhat et al. | Feb 2019 | S |
D844013 | Peeters et al. | Mar 2019 | S |
D857034 | Hung et al. | Aug 2019 | S |
D874492 | Henderson | Feb 2020 | S |
D875742 | Kang et al. | Feb 2020 | S |
D877171 | Poindexter et al. | Mar 2020 | S |
D881904 | Angeles et al. | Apr 2020 | S |
D902412 | Angeles et al. | Nov 2020 | S |
20020016588 | Wong et al. | Feb 2002 | A1 |
20020049464 | Donofrio et al. | Apr 2002 | A1 |
20020087155 | Underwood et al. | Jul 2002 | A1 |
20020128641 | Underwood et al. | Sep 2002 | A1 |
20030139789 | Tvinnereim | Jul 2003 | A1 |
20030144659 | Edwards | Jul 2003 | A1 |
20030208194 | Hovda et al. | Nov 2003 | A1 |
20030225403 | Woloszko et al. | Dec 2003 | A1 |
20040220644 | Shalev et al. | Nov 2004 | A1 |
20050020901 | Belson | Jan 2005 | A1 |
20050119643 | Sobol et al. | Jun 2005 | A1 |
20050222565 | Manstein | Oct 2005 | A1 |
20050234439 | Underwood | Oct 2005 | A1 |
20050240147 | Makower et al. | Oct 2005 | A1 |
20050288655 | Root et al. | Dec 2005 | A1 |
20050288665 | Woloszko et al. | Dec 2005 | A1 |
20060235377 | Earley | Oct 2006 | A1 |
20060253117 | Hovda et al. | Nov 2006 | A1 |
20060276817 | Vassallo et al. | Dec 2006 | A1 |
20060276861 | Lin | Dec 2006 | A1 |
20070066944 | Nyte | Mar 2007 | A1 |
20070073282 | McGarrigan et al. | Mar 2007 | A1 |
20070219600 | Gertner et al. | Sep 2007 | A1 |
20080027423 | Choi et al. | Jan 2008 | A1 |
20080027480 | van der Burg et al. | Jan 2008 | A1 |
20080082090 | Manstein | Apr 2008 | A1 |
20080125626 | Chang et al. | May 2008 | A1 |
20080312644 | Fourkas | Dec 2008 | A1 |
20090018485 | Krespi et al. | Jan 2009 | A1 |
20090124958 | Li | May 2009 | A1 |
20090143821 | Stupak | Jun 2009 | A1 |
20090292358 | Saidi | Nov 2009 | A1 |
20100144996 | Kennedy et al. | Jun 2010 | A1 |
20100152730 | Makower et al. | Jun 2010 | A1 |
20100174283 | McNall | Jul 2010 | A1 |
20100241112 | Watson | Sep 2010 | A1 |
20110009737 | Manstein | Jan 2011 | A1 |
20110282268 | Baker et al. | Nov 2011 | A1 |
20120039954 | Cupit et al. | Feb 2012 | A1 |
20120078377 | Gonzales et al. | Mar 2012 | A1 |
20120298105 | Osorio | Nov 2012 | A1 |
20120316473 | Bonutti et al. | Dec 2012 | A1 |
20120316557 | Sartor et al. | Dec 2012 | A1 |
20120323227 | Wolf et al. | Dec 2012 | A1 |
20120323232 | Wolf et al. | Dec 2012 | A1 |
20130218158 | Danek et al. | Aug 2013 | A1 |
20140088463 | Wolf | Mar 2014 | A1 |
20140114233 | Deem et al. | Apr 2014 | A1 |
20150202003 | Wolf et al. | Jul 2015 | A1 |
20160058336 | Blahnik et al. | Mar 2016 | A1 |
20160317803 | Sama | Nov 2016 | A1 |
20170095288 | Wolf et al. | Apr 2017 | A1 |
20170209199 | Wolf et al. | Jul 2017 | A1 |
20170224987 | Kent et al. | Aug 2017 | A1 |
20170231651 | Dinger et al. | Aug 2017 | A1 |
20170245924 | Wolf et al. | Aug 2017 | A1 |
20170252089 | Hester | Sep 2017 | A1 |
20170252100 | Wolf et al. | Sep 2017 | A1 |
20170357419 | Raymann et al. | Dec 2017 | A1 |
20170360495 | Wolf et al. | Dec 2017 | A1 |
20180000535 | Wolf et al. | Jan 2018 | A1 |
20180177542 | Wolf et al. | Jun 2018 | A1 |
20180185085 | Wolf et al. | Jul 2018 | A1 |
20180228533 | Wolf et al. | Aug 2018 | A1 |
20180263678 | Saadat | Sep 2018 | A1 |
20180317997 | Dinger et al. | Nov 2018 | A1 |
20200129223 | Angeles et al. | Apr 2020 | A1 |
20200268439 | Frazier et al. | Aug 2020 | A1 |
Number | Date | Country |
---|---|---|
2621723 | Jun 2004 | CN |
101325919 | Dec 2008 | CN |
101883606 | Nov 2010 | CN |
103055417 | Apr 2013 | CN |
102007006467 | Mar 2008 | DE |
199907299 | Feb 1999 | WO |
2001043653 | Jun 2001 | WO |
2003024349 | Mar 2003 | WO |
2007037895 | Apr 2007 | WO |
2007134005 | Nov 2007 | WO |
WO2009048580 | Apr 2009 | WO |
2010077980 | Jul 2010 | WO |
2012174161 | Dec 2012 | WO |
2015047863 | Apr 2015 | WO |
2015048806 | Apr 2015 | WO |
2015153696 | Oct 2015 | WO |
Entry |
---|
International Search Report and Written Opinion for PCT/US2017/067596, dated Mar. 14, 2018, 15 pages. |
Nesmiyanov, Nikita. “12 Open Source/Commercial Control Panels for Virtual Machines (VM's) Management.” TecMint, published Jul. 28, 2016 (Retrieved from the Internet Feb. 19, 2020). Internet URL: <https://www.tecmint.com/opensource-commercial-control-panels-manage-virtual-machines/> (Year: 2016). |
“Electrosurgery Console”, U.S. Appl. No. 29/668,608, filed Oct. 31, 2018, 12 pages. |
“Non-Invasive Nasal Airway Remodeling.” Aerin Medical, published Sep. 27, 2017 (Retrieved from the Internet Jan. 30, 2020). |
Darville, Fabien. “Progress Bar.” Behance, published May 3, 2013 (Retrieved from the Internet Jan. 30, 2020). Internet URL: <https://www .behance.net/gallery18490779/Progress-bar> (Year: 2013). |
Number | Date | Country | |
---|---|---|---|
20180177546 A1 | Jun 2018 | US |
Number | Date | Country | |
---|---|---|---|
62438300 | Dec 2016 | US |